The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability. Moliné-Velázquez V, Ortega M C, Vila Del Sol V, Melero-Jerez C, de Castro F, Clemente D Neurobiol Dis. 2014 Apr 5. PMID: 24709559. Abstract CommentRecommendBookmarkWatch